FASTURTEC POWDER FOR SOLUTION FOR INFUSION 1.5 mg/vial
Product details
Registration number: SIN12055P
Classification: Prescription Only
Active ingredients: RASBURICASE
Strength: 1.5 mg/vial
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Registrant: SANOFI-AVENTIS SINGAPORE PTE. LTD.
ATC code: V03AF07
HSA approval date: 27 August 2002
Manufacturer(s):
- SANOFI WINTHROP INDUSTRIE (Solvent manufacturer)
- Sanofi S.r.l. (Powder and Solvent manufaturer)
Manufacturing country/countries: FRANCE; ITALY
What are the HSA registration number and classification for FASTURTEC POWDER FOR SOLUTION FOR INFUSION 1.5 mg/vial?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN12055P
Classification: Prescription Only
What active ingredients and strength are recorded for FASTURTEC POWDER FOR SOLUTION FOR INFUSION 1.5 mg/vial?
According to the HSA dataset updated 7 August 2026:
Active ingredients: RASBURICASE
Strength: 1.5 mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for FASTURTEC POWDER FOR SOLUTION FOR INFUSION 1.5 mg/vial?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for FASTURTEC POWDER FOR SOLUTION FOR INFUSION 1.5 mg/vial?
According to the HSA dataset updated 7 August 2026:
Registrant: SANOFI-AVENTIS SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for FASTURTEC POWDER FOR SOLUTION FOR INFUSION 1.5 mg/vial?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- SANOFI WINTHROP INDUSTRIE (Solvent manufacturer)
- Sanofi S.r.l. (Powder and Solvent manufaturer)
Manufacturing country/countries: FRANCE; ITALY
Where can I look up FASTURTEC POWDER FOR SOLUTION FOR INFUSION 1.5 mg/vial in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN12055P or the exact product name FASTURTEC POWDER FOR SOLUTION FOR INFUSION 1.5 mg/vial. The general register link does not preselect this product.
What are the source dates for this FASTURTEC POWDER FOR SOLUTION FOR INFUSION 1.5 mg/vial record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this FASTURTEC POWDER FOR SOLUTION FOR INFUSION 1.5 mg/vial record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN12055P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)